rAAV9.CMV.hNAGLU
ABT-002
Phase 2 mab terminated
Quick answer
rAAV9.CMV.hNAGLU for Mucopolysaccharidosis Type 3 B is a Phase 2 program (mab) at ABEONA THERAPEUTICS INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- ABEONA THERAPEUTICS INC.
- Indication
- Mucopolysaccharidosis Type 3 B
- Phase
- Phase 2
- Modality
- mab
- Status
- terminated